trastuzumab deruxtecan,ado-trastuzumab emtansine
astrazeneca,daiichi sankyo,novartis,roche
['ca,022,001', 'rux,(-crux),(-trux)', 'destiny,breast,4', 'destiny,breast,6', 'trastuzumab deruxtecan', 'destiny,breast,3', 'ser,155,001', 'pertuzumab', 'ca,224,047', 's202', 'breast', 'ca,022,i', '047,(-nct047),(-0.047%)', 't-dxd', 'destiny,breast,2', 'aura ,(-laura)']
destiny-breast03:
trastuzumab deruxtecan tdm1 siginificantly better oncological outcome with t-dxd similar g3-4 aes, more ild with t-dxd(no g4-5) #sabcs2022 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni